

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.15371018 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.15371018 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.15371018 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.15371018 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.15371018 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.15371018 |
| 7 | microglial cell activation (GO:0001774) | 7.04791276 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.78478296 |
| 9 | cytidine deamination (GO:0009972) | 6.38529010 |
| 10 | cytidine metabolic process (GO:0046087) | 6.38529010 |
| 11 | cytidine catabolic process (GO:0006216) | 6.38529010 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.22001854 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.87220053 |
| 14 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.70694406 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35307580 |
| 16 | eosinophil chemotaxis (GO:0048245) | 5.17976300 |
| 17 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.91915270 |
| 18 | DNA deamination (GO:0045006) | 4.80195638 |
| 19 | macrophage activation (GO:0042116) | 4.72562609 |
| 20 | eosinophil migration (GO:0072677) | 4.66551289 |
| 21 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.57907862 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.57737620 |
| 23 | response to host immune response (GO:0052572) | 4.57737620 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.47478053 |
| 25 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.47197938 |
| 26 | positive regulation of chemokine secretion (GO:0090197) | 4.31700719 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 4.31071251 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.27657303 |
| 29 | response to host (GO:0075136) | 4.27657303 |
| 30 | response to host defenses (GO:0052200) | 4.27657303 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 4.21204296 |
| 32 | cellular extravasation (GO:0045123) | 4.19772621 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.99043214 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97573289 |
| 35 | positive regulation of lymphocyte migration (GO:2000403) | 3.97318997 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.97097197 |
| 37 | I-kappaB phosphorylation (GO:0007252) | 3.89523987 |
| 38 | lymphocyte chemotaxis (GO:0048247) | 3.81256350 |
| 39 | macrophage chemotaxis (GO:0048246) | 3.80665513 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.75011790 |
| 41 | T cell migration (GO:0072678) | 3.73318950 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 3.70500959 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.70079931 |
| 44 | regulation of antigen processing and presentation (GO:0002577) | 3.65081829 |
| 45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.58046550 |
| 46 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.55951570 |
| 47 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.54179690 |
| 48 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.52852620 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 3.51942797 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.51229524 |
| 51 | response to peptidoglycan (GO:0032494) | 3.48152881 |
| 52 | regulation of lymphocyte migration (GO:2000401) | 3.47213961 |
| 53 | pinocytosis (GO:0006907) | 3.46428029 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 3.43715865 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42842231 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.42382763 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.42213709 |
| 58 | negative regulation of cell killing (GO:0031342) | 3.41754952 |
| 59 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41754952 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 3.37317901 |
| 61 | regulation of chemokine secretion (GO:0090196) | 3.33299797 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.32424433 |
| 63 | respiratory burst (GO:0045730) | 3.31930055 |
| 64 | regulation of regulatory T cell differentiation (GO:0045589) | 3.30675752 |
| 65 | phagocytosis, engulfment (GO:0006911) | 3.25106058 |
| 66 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.24973085 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.22259375 |
| 68 | response to interleukin-15 (GO:0070672) | 3.21407333 |
| 69 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.20318865 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19774193 |
| 71 | tolerance induction (GO:0002507) | 3.19715830 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.19092478 |
| 73 | myeloid leukocyte activation (GO:0002274) | 3.17827298 |
| 74 | B cell mediated immunity (GO:0019724) | 3.16537435 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15649808 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15649808 |
| 77 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.14643208 |
| 78 | positive regulation of T cell chemotaxis (GO:0010820) | 3.13841240 |
| 79 | regulation of T cell chemotaxis (GO:0010819) | 3.13841240 |
| 80 | regulation of mononuclear cell migration (GO:0071675) | 3.12630533 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12090629 |
| 82 | positive T cell selection (GO:0043368) | 3.11932882 |
| 83 | regulation of macrophage chemotaxis (GO:0010758) | 3.11692784 |
| 84 | negative regulation by host of viral transcription (GO:0043922) | 3.11318635 |
| 85 | positive regulation of tolerance induction (GO:0002645) | 3.10215433 |
| 86 | response to muramyl dipeptide (GO:0032495) | 3.09211195 |
| 87 | positive regulation of B cell differentiation (GO:0045579) | 3.08884361 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08454396 |
| 89 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.07322237 |
| 90 | regulation of activation of Janus kinase activity (GO:0010533) | 3.06889057 |
| 91 | hyaluronan catabolic process (GO:0030214) | 3.05499593 |
| 92 | neutrophil activation (GO:0042119) | 3.04926688 |
| 93 | positive regulation of defense response to virus by host (GO:0002230) | 3.04799745 |
| 94 | positive regulation of T cell migration (GO:2000406) | 3.04538812 |
| 95 | glycolipid catabolic process (GO:0019377) | 3.03866102 |
| 96 | germ cell migration (GO:0008354) | 3.03201881 |
| 97 | T cell costimulation (GO:0031295) | 3.03078470 |
| 98 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.02666327 |
| 99 | amino sugar catabolic process (GO:0046348) | 3.02501482 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 3.02009690 |
| 101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01901566 |
| 102 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01802988 |
| 103 | positive regulation of chemokine production (GO:0032722) | 3.01620142 |
| 104 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00611034 |
| 105 | positive regulation of macrophage differentiation (GO:0045651) | 2.99242284 |
| 106 | lymphocyte costimulation (GO:0031294) | 2.99150721 |
| 107 | granulocyte activation (GO:0036230) | 2.98497632 |
| 108 | interferon-gamma production (GO:0032609) | 2.96809121 |
| 109 | positive regulation of mast cell activation (GO:0033005) | 2.96290231 |
| 110 | regulation of mast cell activation (GO:0033003) | 2.96241613 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.95431689 |
| 112 | germinal center formation (GO:0002467) | 2.93825488 |
| 113 | negative regulation of B cell proliferation (GO:0030889) | 2.92376937 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.91932299 |
| 115 | negative regulation of viral genome replication (GO:0045071) | 2.90664199 |
| 116 | B cell receptor signaling pathway (GO:0050853) | 2.88849102 |
| 117 | B cell homeostasis (GO:0001782) | 2.88819227 |
| 118 | oligosaccharide catabolic process (GO:0009313) | 2.88724399 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88340246 |
| 120 | ceramide catabolic process (GO:0046514) | 2.87902316 |
| 121 | monocyte chemotaxis (GO:0002548) | 2.87078886 |
| 122 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.86593570 |
| 123 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.85630976 |
| 124 | regulation of T cell migration (GO:2000404) | 2.84533100 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 2.83256008 |
| 126 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83008971 |
| 127 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82538313 |
| 128 | positive regulation of mast cell degranulation (GO:0043306) | 2.82538313 |
| 129 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.82451987 |
| 130 | regulation of calcium-mediated signaling (GO:0050848) | 2.82277985 |
| 131 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.82044825 |
| 132 | positive regulation of neutrophil migration (GO:1902624) | 2.82044825 |
| 133 | regulation of chronic inflammatory response (GO:0002676) | 2.81425710 |
| 134 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80591254 |
| 135 | actin nucleation (GO:0045010) | 2.80458937 |
| 136 | positive thymic T cell selection (GO:0045059) | 2.78475352 |
| 137 | mature B cell differentiation (GO:0002335) | 2.78446398 |
| 138 | chemokine-mediated signaling pathway (GO:0070098) | 2.78433535 |
| 139 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.78423298 |
| 140 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.77094549 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.75509985 |
| 142 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75432918 |
| 143 | negative T cell selection (GO:0043383) | 2.75268625 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.71878926 |
| 145 | purinergic receptor signaling pathway (GO:0035587) | 2.71587121 |
| 146 | negative regulation of interleukin-17 production (GO:0032700) | 2.71457108 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 2.70183407 |
| 148 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.69679211 |
| 149 | leukocyte aggregation (GO:0070486) | 2.69066844 |
| 150 | response to cholesterol (GO:0070723) | 2.67392604 |
| 151 | cellular defense response (GO:0006968) | 2.67162645 |
| 152 | regulation of monocyte chemotaxis (GO:0090025) | 2.66423840 |
| 153 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.65816664 |
| 154 | regulation of B cell differentiation (GO:0045577) | 2.65632506 |
| 155 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65052336 |
| 156 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.63415988 |
| 157 | negative regulation of mast cell activation (GO:0033004) | 2.62032593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.06816979 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.79461244 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.95352508 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.79968343 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70011756 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.35132131 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.88308977 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.68393291 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62005363 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37244915 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.33411510 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.24682093 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.98056260 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90242382 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.87616588 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66371651 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62929666 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.62897345 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31416386 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30719525 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30648790 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.17511469 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16491060 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04213876 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03499584 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02313692 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00276193 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.98345635 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.96022381 |
| 30 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.88427072 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86266479 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82994242 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80685163 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.74188866 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72001994 |
| 36 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69464935 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68946863 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.65362712 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63400694 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61619496 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56455196 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56023276 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.54357968 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50065684 |
| 45 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47985918 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45092437 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41104304 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40932753 |
| 49 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40128258 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38652054 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34853601 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34373608 |
| 53 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33599812 |
| 54 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32597118 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29720823 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27261032 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22747290 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17695723 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15209627 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.14886626 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13778054 |
| 62 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12055834 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08848363 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08194447 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07915959 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06352984 |
| 67 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06192133 |
| 68 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04720420 |
| 69 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04098538 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03117635 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00981379 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99536580 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98850119 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98348351 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97894202 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96848116 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95770857 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95725622 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94842788 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94391072 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93999981 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93560253 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93197878 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90405565 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90402185 |
| 86 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90176866 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89702236 |
| 88 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.89137703 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87461663 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86863918 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86419722 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85472341 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84323300 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 0.84185109 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83783682 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83264230 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82968965 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82605164 |
| 99 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81784709 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80529438 |
| 101 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79313272 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76739304 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76499669 |
| 104 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74669824 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74179603 |
| 106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73925415 |
| 107 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.73619735 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72517967 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72356048 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71435773 |
| 111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70687717 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70505706 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.70148747 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69908390 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68150140 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68061252 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66901902 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65163126 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65139732 |
| 120 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.64799644 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.64083918 |
| 122 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63979998 |
| 123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.63606579 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63273395 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.63111103 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62916502 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62590004 |
| 128 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62526376 |
| 129 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.62390819 |
| 130 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.61893118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.55244162 |
| 2 | MP0006082_CNS_inflammation | 4.19132393 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.63135631 |
| 4 | MP0005671_abnormal_response_to | 3.58895007 |
| 5 | MP0003303_peritoneal_inflammation | 3.35982354 |
| 6 | MP0003436_decreased_susceptibility_to | 3.28215404 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.25122093 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.11409857 |
| 9 | MP0002419_abnormal_innate_immunity | 3.06306777 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.85338897 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.78650508 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.77354805 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.67934306 |
| 14 | MP0004510_myositis | 2.55461820 |
| 15 | MP0001800_abnormal_humoral_immune | 2.52382191 |
| 16 | MP0002723_abnormal_immune_serum | 2.41113081 |
| 17 | MP0001790_abnormal_immune_system | 2.37322707 |
| 18 | MP0005387_immune_system_phenotype | 2.37322707 |
| 19 | MP0005025_abnormal_response_to | 2.29476364 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.28370017 |
| 21 | MP0001819_abnormal_immune_cell | 2.26698759 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.22521395 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.14136898 |
| 24 | MP0009785_altered_susceptibility_to | 2.04814304 |
| 25 | MP0001853_heart_inflammation | 2.01747502 |
| 26 | MP0000685_abnormal_immune_system | 1.93944613 |
| 27 | MP0003724_increased_susceptibility_to | 1.90455922 |
| 28 | MP0002405_respiratory_system_inflammati | 1.82467080 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.79231596 |
| 30 | MP0000343_altered_response_to | 1.74555069 |
| 31 | MP0005310_abnormal_salivary_gland | 1.72926494 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.72335918 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.70863465 |
| 34 | MP0000716_abnormal_immune_system | 1.68088186 |
| 35 | MP0001851_eye_inflammation | 1.67173940 |
| 36 | MP0002398_abnormal_bone_marrow | 1.60360620 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.57770550 |
| 38 | MP0003690_abnormal_glial_cell | 1.57058849 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.56526815 |
| 40 | MP0003828_pulmonary_edema | 1.56208941 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.55158490 |
| 42 | MP0003075_altered_response_to | 1.54402199 |
| 43 | MP0004947_skin_inflammation | 1.53912102 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.52975583 |
| 45 | MP0003448_altered_tumor_morphology | 1.49676074 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.48051127 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.46702865 |
| 48 | MP0008469_abnormal_protein_level | 1.44951217 |
| 49 | MP0009840_abnormal_foam_cell | 1.40514195 |
| 50 | MP0003195_calcinosis | 1.40195375 |
| 51 | MP0002722_abnormal_immune_system | 1.37297024 |
| 52 | MP0002429_abnormal_blood_cell | 1.34774621 |
| 53 | MP0008004_abnormal_stomach_pH | 1.34439212 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.33374521 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.31807749 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.31563893 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.31451371 |
| 58 | MP0005166_decreased_susceptibility_to | 1.30899330 |
| 59 | MP0002933_joint_inflammation | 1.29287966 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.25202959 |
| 61 | MP0001873_stomach_inflammation | 1.22120170 |
| 62 | MP0003045_fibrosis | 1.20395669 |
| 63 | MP0009278_abnormal_bone_marrow | 1.18281608 |
| 64 | MP0003329_amyloid_beta_deposits | 1.14330754 |
| 65 | MP0000858_altered_metastatic_potential | 1.12036270 |
| 66 | MP0005390_skeleton_phenotype | 1.08212043 |
| 67 | MP0010307_abnormal_tumor_latency | 1.07059299 |
| 68 | MP0002006_tumorigenesis | 1.06858104 |
| 69 | MP0002090_abnormal_vision | 1.06217503 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.04475161 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.04061329 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.04061329 |
| 73 | MP0009764_decreased_sensitivity_to | 1.03123251 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.01654677 |
| 75 | MP0002254_reproductive_system_inflammat | 1.00434404 |
| 76 | MP0000604_amyloidosis | 0.99017153 |
| 77 | MP0000249_abnormal_blood_vessel | 0.97996388 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.94886011 |
| 79 | MP0002928_abnormal_bile_duct | 0.94260949 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.92956359 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.91685759 |
| 82 | MP0003763_abnormal_thymus_physiology | 0.88164929 |
| 83 | MP0005023_abnormal_wound_healing | 0.85243583 |
| 84 | MP0004883_abnormal_blood_vessel | 0.85220196 |
| 85 | MP0001915_intracranial_hemorrhage | 0.84234636 |
| 86 | MP0000371_diluted_coat_color | 0.83918428 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.82812595 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.81970770 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.81912914 |
| 90 | MP0003795_abnormal_bone_structure | 0.79731071 |
| 91 | MP0005165_increased_susceptibility_to | 0.78599243 |
| 92 | MP0000920_abnormal_myelination | 0.77689943 |
| 93 | MP0000490_abnormal_crypts_of | 0.77189204 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.75592800 |
| 95 | MP0005164_abnormal_response_to | 0.74056727 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.73410077 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.72354327 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.70555741 |
| 99 | MP0009763_increased_sensitivity_to | 0.69858251 |
| 100 | MP0003091_abnormal_cell_migration | 0.69850757 |
| 101 | MP0005365_abnormal_bile_salt | 0.68544117 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.68303166 |
| 103 | MP0003252_abnormal_bile_duct | 0.66571350 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66417684 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.66003562 |
| 106 | MP0003279_aneurysm | 0.65436884 |
| 107 | MP0008873_increased_physiological_sensi | 0.65200004 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.64654281 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.63123953 |
| 110 | MP0003866_abnormal_defecation | 0.61343576 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.60771330 |
| 112 | MP0001542_abnormal_bone_strength | 0.58904012 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.58639963 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.58410322 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.58304956 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.55068746 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.53349921 |
| 118 | MP0005451_abnormal_body_composition | 0.52384901 |
| 119 | MP0001663_abnormal_digestive_system | 0.52220879 |
| 120 | MP0004742_abnormal_vestibular_system | 0.51328455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.39635898 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.06705735 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.88166825 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.69638599 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.51946114 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.51946114 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.51946114 |
| 8 | T lymphocytopenia (HP:0005403) | 5.34040529 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 5.10076664 |
| 10 | Abnormality of T cell number (HP:0011839) | 5.01261569 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.69272412 |
| 12 | Glomerulonephritis (HP:0000099) | 4.67545006 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.30093042 |
| 14 | Arterial tortuosity (HP:0005116) | 4.28578536 |
| 15 | Cerebral aneurysm (HP:0004944) | 4.19182642 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.90149377 |
| 17 | Vascular tortuosity (HP:0004948) | 3.77155805 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69456011 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.57009625 |
| 20 | Recurrent skin infections (HP:0001581) | 3.40160247 |
| 21 | Disinhibition (HP:0000734) | 3.39863114 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.36332388 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.36332388 |
| 24 | Axonal loss (HP:0003447) | 3.36208225 |
| 25 | Myositis (HP:0100614) | 3.33009471 |
| 26 | Abnormality of T cells (HP:0002843) | 3.32848035 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.30037111 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.30037111 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.30037111 |
| 30 | Complement deficiency (HP:0004431) | 3.23854823 |
| 31 | Aortic aneurysm (HP:0004942) | 3.18589503 |
| 32 | Hematochezia (HP:0002573) | 3.16976360 |
| 33 | Retinal atrophy (HP:0001105) | 3.11244166 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08746401 |
| 35 | Abnormality of the prostate (HP:0008775) | 3.06918727 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.06651917 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06264784 |
| 38 | Obstructive lung disease (HP:0006536) | 3.06264784 |
| 39 | Abnormality of complement system (HP:0005339) | 2.96317745 |
| 40 | Agnosia (HP:0010524) | 2.91994960 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.91730736 |
| 42 | Chronic diarrhea (HP:0002028) | 2.87357771 |
| 43 | Pathologic fracture (HP:0002756) | 2.81276131 |
| 44 | Encephalitis (HP:0002383) | 2.80651939 |
| 45 | Orchitis (HP:0100796) | 2.78672481 |
| 46 | Aortic dissection (HP:0002647) | 2.72599027 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71572908 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71572908 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.70857558 |
| 50 | Optic neuritis (HP:0100653) | 2.70857558 |
| 51 | Nephritis (HP:0000123) | 2.69646893 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.68976075 |
| 53 | Gingivitis (HP:0000230) | 2.68177541 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.68136486 |
| 55 | Loss of speech (HP:0002371) | 2.66528260 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.64893325 |
| 57 | Hemiplegia (HP:0002301) | 2.58966290 |
| 58 | Myocardial infarction (HP:0001658) | 2.56324541 |
| 59 | Tetraparesis (HP:0002273) | 2.56030010 |
| 60 | Increased serum ferritin (HP:0003281) | 2.55459988 |
| 61 | Disproportionate tall stature (HP:0001519) | 2.53002483 |
| 62 | Mutism (HP:0002300) | 2.52978450 |
| 63 | Progressive visual loss (HP:0000529) | 2.49656709 |
| 64 | Thick nail (HP:0001805) | 2.49246053 |
| 65 | Colitis (HP:0002583) | 2.47468000 |
| 66 | Increased IgM level (HP:0003496) | 2.46293266 |
| 67 | Polyneuropathy (HP:0001271) | 2.45691303 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.43618159 |
| 69 | IgG deficiency (HP:0004315) | 2.42728589 |
| 70 | Gangrene (HP:0100758) | 2.42002078 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41871448 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.41871448 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.41366790 |
| 74 | Chest pain (HP:0100749) | 2.41148786 |
| 75 | Recurrent viral infections (HP:0004429) | 2.40051599 |
| 76 | Prostate neoplasm (HP:0100787) | 2.39698874 |
| 77 | Pustule (HP:0200039) | 2.39379358 |
| 78 | Hypoproteinemia (HP:0003075) | 2.39156770 |
| 79 | Striae distensae (HP:0001065) | 2.36577708 |
| 80 | Increased CSF protein (HP:0002922) | 2.34598684 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.33714867 |
| 82 | Stomatitis (HP:0010280) | 2.33316784 |
| 83 | Arterial thrombosis (HP:0004420) | 2.30989968 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.29908976 |
| 85 | Periodontitis (HP:0000704) | 2.27135384 |
| 86 | Spondylolisthesis (HP:0003302) | 2.27062289 |
| 87 | Pulmonary embolism (HP:0002204) | 2.25342484 |
| 88 | Joint swelling (HP:0001386) | 2.24476925 |
| 89 | Eosinophilia (HP:0001880) | 2.22880280 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.22678177 |
| 91 | Vasculitis (HP:0002633) | 2.21406326 |
| 92 | Vertebral compression fractures (HP:0002953) | 2.20813261 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 2.19447011 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.19042022 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 2.18684992 |
| 96 | Urethral obstruction (HP:0000796) | 2.17629326 |
| 97 | Bone pain (HP:0002653) | 2.16207773 |
| 98 | Pulmonary fibrosis (HP:0002206) | 2.15614797 |
| 99 | Cellulitis (HP:0100658) | 2.15579738 |
| 100 | Recurrent pneumonia (HP:0006532) | 2.15486921 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.15163657 |
| 102 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14838098 |
| 103 | Meningitis (HP:0001287) | 2.14436577 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.13914542 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.11345697 |
| 106 | Abnormal platelet function (HP:0011869) | 2.10713708 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.10713708 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.09719413 |
| 109 | Neurofibrillary tangles (HP:0002185) | 2.09585299 |
| 110 | Chronic otitis media (HP:0000389) | 2.08631784 |
| 111 | Osteomyelitis (HP:0002754) | 2.08217393 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.07571535 |
| 113 | Leukocytosis (HP:0001974) | 2.07411641 |
| 114 | Gingival bleeding (HP:0000225) | 2.06797841 |
| 115 | Cheilitis (HP:0100825) | 2.06343638 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.06319482 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.05829101 |
| 118 | Petechiae (HP:0000967) | 2.05518672 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 2.04923120 |
| 120 | Severe combined immunodeficiency (HP:0004430) | 2.04731047 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 2.02988477 |
| 122 | Granulocytopenia (HP:0001913) | 2.02857092 |
| 123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02823938 |
| 124 | Thoracic kyphosis (HP:0002942) | 2.02783669 |
| 125 | Pulmonary infiltrates (HP:0002113) | 2.02752580 |
| 126 | J-shaped sella turcica (HP:0002680) | 2.01406021 |
| 127 | Urticaria (HP:0001025) | 2.01323299 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 2.00611024 |
| 129 | Hemoptysis (HP:0002105) | 1.98650135 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98228416 |
| 131 | Amaurosis fugax (HP:0100576) | 1.98087409 |
| 132 | Aplastic anemia (HP:0001915) | 1.97984036 |
| 133 | Purpura (HP:0000979) | 1.97791030 |
| 134 | Recurrent bronchitis (HP:0002837) | 1.97474919 |
| 135 | Premature loss of primary teeth (HP:0006323) | 1.94947955 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.92782239 |
| 137 | IgM deficiency (HP:0002850) | 1.91609244 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.91003051 |
| 139 | Inappropriate behavior (HP:0000719) | 1.90796959 |
| 140 | Albinism (HP:0001022) | 1.89924311 |
| 141 | Thyroiditis (HP:0100646) | 1.89503780 |
| 142 | Abnormality of T cell physiology (HP:0011840) | 1.88684443 |
| 143 | Global brain atrophy (HP:0002283) | 1.87867282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 7.03816633 |
| 2 | GRK7 | 3.31369997 |
| 3 | MAP4K1 | 2.86694773 |
| 4 | TYK2 | 2.84434522 |
| 5 | CSF1R | 2.73754417 |
| 6 | MAPK15 | 2.60460316 |
| 7 | MAP3K14 | 2.60053557 |
| 8 | IRAK4 | 2.55966793 |
| 9 | KIT | 2.51269275 |
| 10 | TBK1 | 2.49533572 |
| 11 | TXK | 2.47671859 |
| 12 | BCKDK | 2.37969386 |
| 13 | KDR | 2.37888043 |
| 14 | RIPK4 | 2.14934507 |
| 15 | ACVR1B | 2.01110505 |
| 16 | STK10 | 1.87803791 |
| 17 | BLK | 1.87398300 |
| 18 | JAK1 | 1.80919691 |
| 19 | IRAK3 | 1.76519126 |
| 20 | CAMK1D | 1.73887611 |
| 21 | ZAP70 | 1.73363189 |
| 22 | IKBKB | 1.61862927 |
| 23 | HCK | 1.61642869 |
| 24 | CSK | 1.61485747 |
| 25 | MAP3K13 | 1.48356498 |
| 26 | NEK9 | 1.44279887 |
| 27 | LYN | 1.43525162 |
| 28 | SYK | 1.39881285 |
| 29 | IKBKE | 1.34882265 |
| 30 | TEC | 1.32570646 |
| 31 | TESK2 | 1.32293870 |
| 32 | MATK | 1.30031784 |
| 33 | RPS6KA4 | 1.26351611 |
| 34 | BMPR2 | 1.26307156 |
| 35 | MAP2K3 | 1.23347676 |
| 36 | CAMK1G | 1.21659754 |
| 37 | PAK4 | 1.21378201 |
| 38 | JAK3 | 1.20657818 |
| 39 | ADRBK2 | 1.20086020 |
| 40 | LCK | 1.19714159 |
| 41 | BTK | 1.17696930 |
| 42 | TAOK3 | 1.17553363 |
| 43 | FES | 1.17345840 |
| 44 | SIK3 | 1.16607988 |
| 45 | MAP3K11 | 1.16539813 |
| 46 | SIK2 | 1.13485363 |
| 47 | DAPK2 | 1.13264627 |
| 48 | TNK2 | 1.12221980 |
| 49 | * ITK | 1.12209738 |
| 50 | PDK2 | 1.02845734 |
| 51 | MARK3 | 1.00953646 |
| 52 | MOS | 1.00869618 |
| 53 | FGR | 0.97701368 |
| 54 | JAK2 | 0.94902777 |
| 55 | MAP2K6 | 0.94840736 |
| 56 | EPHB1 | 0.94525574 |
| 57 | CHUK | 0.93916022 |
| 58 | CLK1 | 0.92481565 |
| 59 | MAP3K3 | 0.91923360 |
| 60 | MAPKAPK2 | 0.85596461 |
| 61 | ERN1 | 0.85180308 |
| 62 | CDK12 | 0.82117197 |
| 63 | IRAK1 | 0.80341921 |
| 64 | PIK3CA | 0.78969793 |
| 65 | MAPK12 | 0.78369459 |
| 66 | CDK3 | 0.75096362 |
| 67 | FRK | 0.73822802 |
| 68 | CAMKK2 | 0.73556426 |
| 69 | MAPK7 | 0.73370078 |
| 70 | CDK6 | 0.73278608 |
| 71 | TYRO3 | 0.71952733 |
| 72 | TSSK6 | 0.70419328 |
| 73 | TRPM7 | 0.70172677 |
| 74 | FGFR3 | 0.67859860 |
| 75 | PIK3CG | 0.67325660 |
| 76 | STK24 | 0.67064558 |
| 77 | EEF2K | 0.66382563 |
| 78 | ABL2 | 0.64699969 |
| 79 | PIM1 | 0.61816457 |
| 80 | MAPKAPK3 | 0.60107281 |
| 81 | IGF1R | 0.58144645 |
| 82 | EGFR | 0.57207965 |
| 83 | DDR2 | 0.56652043 |
| 84 | MAP3K1 | 0.54747280 |
| 85 | CAMKK1 | 0.54095605 |
| 86 | PRKCQ | 0.52257823 |
| 87 | TLK1 | 0.51148396 |
| 88 | VRK1 | 0.50636614 |
| 89 | DMPK | 0.50147104 |
| 90 | PDK1 | 0.49686554 |
| 91 | SCYL2 | 0.49554325 |
| 92 | EIF2AK2 | 0.49486842 |
| 93 | PAK2 | 0.47638606 |
| 94 | FGFR4 | 0.47151022 |
| 95 | CAMK4 | 0.46810370 |
| 96 | CDC42BPA | 0.46717210 |
| 97 | MELK | 0.45247708 |
| 98 | EPHA3 | 0.44686300 |
| 99 | BMPR1B | 0.43409378 |
| 100 | TTN | 0.43007870 |
| 101 | MAPK4 | 0.42384256 |
| 102 | PRKCD | 0.42361666 |
| 103 | TAOK2 | 0.42214761 |
| 104 | MST4 | 0.41673784 |
| 105 | STK4 | 0.41274808 |
| 106 | PRKAA2 | 0.39474262 |
| 107 | TAOK1 | 0.37895154 |
| 108 | GSK3A | 0.37709209 |
| 109 | GRK6 | 0.35498695 |
| 110 | NUAK1 | 0.35196899 |
| 111 | INSR | 0.34838444 |
| 112 | TGFBR1 | 0.34082607 |
| 113 | ABL1 | 0.33995356 |
| 114 | PTK6 | 0.33900092 |
| 115 | GRK1 | 0.32747629 |
| 116 | STK3 | 0.32669556 |
| 117 | PKN2 | 0.32491364 |
| 118 | PDPK1 | 0.30964865 |
| 119 | FYN | 0.30819711 |
| 120 | SGK3 | 0.30138347 |
| 121 | PDGFRB | 0.28142487 |
| 122 | PIM2 | 0.27645279 |
| 123 | MAPKAPK5 | 0.27595173 |
| 124 | RPS6KA6 | 0.25936243 |
| 125 | MAP4K2 | 0.25679644 |
| 126 | PKN1 | 0.25485445 |
| 127 | EIF2AK3 | 0.25181039 |
| 128 | PRKCA | 0.24011482 |
| 129 | LIMK1 | 0.23251428 |
| 130 | MAP2K7 | 0.23029140 |
| 131 | MAP3K8 | 0.22774280 |
| 132 | SRC | 0.22409436 |
| 133 | PRKD1 | 0.22232282 |
| 134 | PINK1 | 0.20715130 |
| 135 | MAP3K5 | 0.20116909 |
| 136 | PRKACG | 0.19466275 |
| 137 | NME2 | 0.18529320 |
| 138 | INSRR | 0.17000458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.60750441 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.25486541 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.89630315 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.83287284 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78826839 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67720676 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37575984 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.32502139 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.20764631 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19977137 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18912849 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02127510 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.98159889 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94683849 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.94496788 |
| 16 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.92704653 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.90206085 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77400078 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72961696 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.67568212 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60298985 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.59429292 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56563197 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.55059845 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54319482 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.46508568 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.46397886 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40163133 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37075637 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.37069484 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.33443459 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33278079 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33268500 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32070928 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.29671308 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27156126 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21436688 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.20468717 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18662875 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15810963 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15072479 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13814387 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.12641031 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.11193330 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08775419 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03626603 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.01472424 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98364416 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96901945 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96553031 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95490279 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95191488 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91827467 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89472389 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.87387203 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84316703 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83480164 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77638030 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.77064673 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75595820 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.73937394 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73228900 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73131994 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72979701 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.71139669 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69647286 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68894159 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68433876 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65134311 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63422105 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60922738 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 0.59720231 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.59311379 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59051689 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58870854 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57937823 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57043478 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55204973 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.54763647 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54232042 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.53484361 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51194071 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51014137 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50434603 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48350806 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47724912 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46956281 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45572362 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44636750 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44252803 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43557797 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42407998 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42357854 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41343893 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40698383 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.39787971 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39177456 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38384456 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38223108 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37961397 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37622889 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36329402 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35617806 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32874858 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32093950 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.31808094 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29622126 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28784558 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27921146 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27666556 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27438557 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26678082 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.26606236 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.25557961 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25095023 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24750187 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22374792 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20904603 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17632033 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15278948 |
| 121 | Protein export_Homo sapiens_hsa03060 | 0.13555007 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12142248 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11519903 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10187967 |
| 125 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.10130920 |
| 126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.06677322 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.04638152 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.03999386 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.03793477 |

